• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: THERAKOS, INC. CELLEX PHOTOPHERESIS SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

THERAKOS, INC. CELLEX PHOTOPHERESIS SYSTEM Back to Search Results
Model Number NOT APPLICABLE
Device Problem Device Alarm System (1012)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 10/30/2019
Event Type  malfunction  
Manufacturer Narrative
The system was used for treatment.This case is reportable as a mdr due to the reportable malfunction clot observed in the return line.Since this reportable malfunction is only associated with the kit, this mdr will only be against the kit.A batch record review for kit lot h131 was conducted.There were no non-conformances associated with this lot.This lot met all release requirements.A review of kit lot h131 for the reported issue shows no trends.Trends were reviewed for complaint categories, clot observed, alarm #17: return pressure, and alarm #53: return line air detected.No trends were detected for each complaint category.This assessment is based on the information available at the time of the investigation.At the time of this report, the analysis of the returned smart card is still in progress.A supplemental report will be filed when the analysis is complete.(b)(4).
 
Event Description
The customer contacted mallinckrodt to report blood clots were observed in the return line of their cellex photopheresis kit ("kit") during an extracorporeal photopheresis (ecp) treatment.The customer reported at approximately 650 ml of whole blood processed they received an alarm #17: return pressure alarm and alarm #53: return line air detected alarm.The customer attempted to wash the patient access and run a saline bolus through the return line; however, the customer was unable to resolve the alarm #17 and alarm #53.At 660 ml of whole blood processed the physician decided to end the treatment and manually return the residual blood within the kit to the patient.The customer reported after the patient was disconnected they observed clots in the return line.The customer stated the patient was stable and started a new treatment that was successfully completed.The customer discarded the kit; however, has returned the smart card for evaluation.
 
Manufacturer Narrative
The smart card data was returned for evaluation.A review of the data recorded on the smart card verified prime was completed and blood collection started in double needle mode.The smart card data showed several alarm #16: collect pressure alarms occurred after 626 ml of whole blood was processed.Following the collect pressure alarms many alarm #17: return pressure alarms were received.Also several alarm #53: return line air detected alarms occurred after 646 ml whole blood processed.The reported clotting observed in the return line could not be verified based on the smart card data.The root cause for the alarm #17 return pressure alarms and alarm #53: return line air detected alarms was most likely due to clotting in the return line.The customer reported the patient often has issues with clotting during treatments.Section 2-8 of the cellex operator's manual (1470069 rev5.0) on anticoagulant states "caution: individual patients may require a heparin dosage that varies from the recommended dose to prevent post-treatment bleeding or clotting during a treatment.The physician should review the patient's medical condition, medications and platelet count at the time of treatment and use clinical judgment to establish the optimal heparin dosage for each patient." the root cause for the clotting observed could not be determined based on the available information.No further action is required at this time.This investigation is now complete.Mc: (b)(4).P.T.10-jan-2020.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CELLEX PHOTOPHERESIS SYSTEM
Type of Device
CELLEX PHOTOPHERESIS SYSTEM
Manufacturer (Section D)
THERAKOS, INC.
bedminster NJ 07921
MDR Report Key9390388
MDR Text Key196090636
Report Number2523595-2019-00142
Device Sequence Number1
Product Code LNR
Combination Product (y/n)N
PMA/PMN Number
P860003
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional
Type of Report Initial,Followup
Report Date 01/10/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date06/01/2021
Device Model NumberNOT APPLICABLE
Device Catalogue NumberCLXECP
Device Lot NumberH131
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 10/30/2019
Initial Date FDA Received11/28/2019
Supplement Dates Manufacturer Received12/11/2019
Supplement Dates FDA Received01/10/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-